Digital Media briefs

Share this article:

Purdue launched RxSafetyMatters, a “new online resource…to help healthcare professionals, law enforcement and community organizations combat the illegal diversion and abuse of prescription medications.” Purdue, whose products include abuse-prone opiates, hosts SafeguardMyMeds.org, for safe storage and disposal of prescription meds. 

Augme Technologies, a mobile marketing technology shop with a substantial healthcare business, acquired Hipcricket, a mobile marketing ad agency based in the Seattle suburbs, for $44.5 million—$6 million of that in cash, the rest in stock. The combined company will have business with ten of the top 20 pharmaceutical companies along with six top media firms and four top agencies. Augme will take on Hipcricket's staff, the shop said, who will continue to handle their old accounts. 

A breast cancer survivor and digital agency founder, Maliet Lopez, launched IHadCancer.com, a social networking site meant to connect cancer survivors, their friends and family. Lopez was a partner at Squeaky Wheel Media when she was diagnosed with breast cancer. She launched the site to help others combat the feeling of isolation she felt during treatment of the disease.


Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro